Source: Program and Abstracts. Conference titles: International Congress of Endocrinology. Unidade: FM
Subjects: CORTISOL (APLICAÇÕES TERAPÊUTICAS), HORMÔNIOS (DEFICIÊNCIA), TERAPIAS COMPLEMENTARES, HIPERPLASIA SUPRARRENAL CONGÊNITA
ABNT
PARENTE, E. et al. Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. 2004, Anais.. Lisboa: International Society of Endocrinology, 2004. . Acesso em: 01 maio 2024.APA
Parente, E., Marquezine, E., Rodrigues, a., Maureira, G., Brenlha, E. M., Ueti, R., et al. (2004). Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. In Program and Abstracts. Lisboa: International Society of Endocrinology.NLM
Parente E, Marquezine E, Rodrigues a., Maureira G, Brenlha EM, Ueti R, Arnhold I, Mendonca BB, Bachega TAS. Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. Program and Abstracts. 2004 ;[citado 2024 maio 01 ]Vancouver
Parente E, Marquezine E, Rodrigues a., Maureira G, Brenlha EM, Ueti R, Arnhold I, Mendonca BB, Bachega TAS. Final heigth in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency treated with cortisone acetate. Program and Abstracts. 2004 ;[citado 2024 maio 01 ]